CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina

Conclusions The decline of EET owing to CYP2C19 variants may affects coronary microvascular dysfunction via chronic inflammation.
Source: IJC Heart and Vasculature - Category: Cardiology Source Type: research